Literature DB >> 32209871

Allergic Contact Dermatitis to Components of Wearable Adhesive Health Devices.

Katherine Khatsenko1, Yupar Khin1, Howard Maibach2.   

Abstract

Consumer use of wearable health devices has been rapidly increasing. Because of prolonged skin contact required, allergic contact dermatitis to components has been reported. Eczematous rash is the most common dermatologic adverse reaction to continuous glucose monitors, and rash from wearable activity trackers is commonly reported by consumers, suggesting that allergic contact dermatitis to wearable health devices may be vastly underreported. Acrylates, methacrylates, and colophonium are the most common allergens found on patch testing. Isobornyl acrylate has been identified as the primary allergen in many cases of allergic contact dermatitis to continuous glucose monitors. These chemicals are found in either the adhesives or the units themselves. Awareness of the presence of these chemicals in wearable devices may provide assistance for diagnostic patch testing in users who have dermatological reactions to the devices and hopefully guide dermatotoxicological evaluation guidance by government and industry.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32209871     DOI: 10.1097/DER.0000000000000575

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  3 in total

1.  Bio-acceptability of wearable sensors: a mechanistic study towards evaluating ionic leaching induced cellular inflammation.

Authors:  Pulak Bhushan; Vivek Kamat; Ishita Abrol; Ajeet Kaushik; Shekhar Bhansali
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

Review 2.  Assessing Pain Research: A Narrative Review of Emerging Pain Methods, Their Technosocial Implications, and Opportunities for Multidisciplinary Approaches.

Authors:  Sara E Berger; Alexis T Baria
Journal:  Front Pain Res (Lausanne)       Date:  2022-06-02

Review 3.  An Evaluation of Biometric Monitoring Technologies for Vital Signs in the Era of COVID-19.

Authors:  Christine Manta; Sneha S Jain; Andrea Coravos; Dena Mendelsohn; Elena S Izmailova
Journal:  Clin Transl Sci       Date:  2020-10-12       Impact factor: 4.689

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.